1. Home
  2. DMAC vs BGS Comparison

DMAC vs BGS Comparison

Compare DMAC & BGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DiaMedica Therapeutics Inc.

DMAC

DiaMedica Therapeutics Inc.

HOLD

Current Price

$9.69

Market Cap

457.2M

Sector

Health Care

ML Signal

HOLD

Logo B&G Foods Inc.

BGS

B&G Foods Inc.

HOLD

Current Price

$4.79

Market Cap

361.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMAC
BGS
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
457.2M
361.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DMAC
BGS
Price
$9.69
$4.79
Analyst Decision
Strong Buy
Hold
Analyst Count
4
3
Target Price
$15.50
$4.67
AVG Volume (30 Days)
529.4K
1.4M
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
16.38%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,840,699,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.19
$3.67
52 Week High
$9.30
$8.10

Technical Indicators

Market Signals
Indicator
DMAC
BGS
Relative Strength Index (RSI) 71.42 61.37
Support Level $7.76 $4.47
Resistance Level $9.23 $4.70
Average True Range (ATR) 0.66 0.13
MACD 0.13 0.02
Stochastic Oscillator 78.29 92.45

Price Performance

Historical Comparison
DMAC
BGS

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.

About BGS B&G Foods Inc.

B&G Foods Inc is an American packaged-food manufacturer. It operate in a single industry segment and manufacture, sell and distribute a diverse portfolio of high-quality shelf-stable and frozen foods across the United States, Canada and Puerto Rico. Its products include frozen and canned vegetables, vegetable, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, The company's main brands are Ac'cent, B&G, B&M, Baker's Joy, Bear Creek Country Kitchens, Cary's, Cream of Rice, Cream of Wheat, Devonsheer, Don Pepino, Durkee, Emeril's, Grandma's Molasses, MacDonald's.

Share on Social Networks: